Manzanita Pharmaceuticals Inc.
San Carlos, CA
- UEI
- J4S6AKLE7EC5
- CAGE
- 4PAW0
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 930 Brittan Ave, San Carlos, CA 94070, USA
- Website
- manzanitapharmaceuticals.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Toxicology (IND-enabling) studies for a novel nerve imaging agent for prostate cancer - abstract translational safety… | National Cancer Institute | $2,902,022 | |
| Nonclinical development of nervelight, an intra-operative peripheral nerve imaging agent | National Cancer Institute | $1,972,907 | |
| Targeted glucocorticoids to reduce chronic pain after acute injury. | Department of the Army | $1,982,238 | |
| In vivo feasibility of a peripheral nerve imaging agent | National Institutes of Health | $288,301 |
Quick answers
What is Manzanita Pharmaceuticals Inc.'s UEI?
Manzanita Pharmaceuticals Inc.'s Unique Entity ID (UEI) in SAM.gov is J4S6AKLE7EC5.
What is Manzanita Pharmaceuticals Inc.'s CAGE code?
Manzanita Pharmaceuticals Inc.'s CAGE code is 4PAW0.
What is Manzanita Pharmaceuticals Inc.'s primary NAICS code?
Manzanita Pharmaceuticals Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Manzanita Pharmaceuticals Inc. located?
Manzanita Pharmaceuticals Inc.'s physical address in SAM.gov is 930 Brittan Ave, San Carlos, CA 94070, USA.
Is Manzanita Pharmaceuticals Inc. registered in SAM.gov?
Yes. Manzanita Pharmaceuticals Inc.'s SAM.gov registration is active through March 9, 2027.
What is Manzanita Pharmaceuticals Inc.'s most recent federal award?
Manzanita Pharmaceuticals Inc.'s most recent federal grant award is Toxicology (IND-enabling) studies for a novel nerve imaging agent for prostate cancer - abstract translational safety… (R44CA295214), from National Cancer Institute, on September 6, 2024.
On GovTribe
See Manzanita Pharmaceuticals Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors